Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy

Frontiers in Neuroenergetics

Volumn , Issue JAN, 2012, Pages

  Mishra, Anusha ^a   Newman, Eric A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetic retinopathy; Functional hyperemia; Inos inhibitors

Indexed keywords

AMINOGUANIDINE; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG EFFICACY; ELECTRORETINOGRAPHY; ENZYME INHIBITION; FUNCTIONAL HYPEREMIA; IN VIVO STUDY; LIGHT EXPOSURE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; VASODILATATION; VISUAL REFLEX;

EID: 84861842059     PISSN: None     EISSN: 16626427     Source Type: Journal    
DOI: 10.3389/fnene.2011.00010     Document Type: Article

References (30)

1. Antonetti, D. A., Barber, A. J., Bron-son, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., Norbury, C. C., Quinn, P. G., Sandirasegarane, L., and Simpson, I. A. (2006). Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55, 2401-2411.
2. Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., and Newman, E. A. (2010). Glial and neuronal control of brain blood flow. Nature 468, 232-243.
3. Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., and Gardner, T. W. (1998). Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102,783-791.
4. Bek, T., Hajari, J., and Jeppesen, P. (2008). Interaction between flicker-induced vasodilatation and pressure autoregulation in early retinopathy of type 2 diabetes. GraefesArch. Clin. Exp. Ophthalmol. 246, 763-769.
5. Berkowitz, B. A., Luan, H., Gupta, R. R., Pacheco, D., Seidner, A., Roberts, R., Liggett, J., Knoerzer, D. L., Connor, J. R., Du, Y., Kern, T. S., and Ito, Y. (2004). Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes 53,173-178.
6. Berkowitz, B. A., Roberts, R., Luan, H., Peysakhov, J., Knoerzer, D. L., Connor, J. R., and Hohman, T. C. (2005). Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest. Ophthalmol Vis. Sci. 46, 2954-2960.
7. Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Rat-ner, R. E., Spinowitz, B. S., Whit-tier, E C., and Wuerth, J. P. (2004). Randomized trial of an inhibitor of formation of advanced gly-cation end products in diabetic nephropathy. Am. J. Nephrol. 24, 32-40.
8. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., and Cerami, A.(1986). Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1632.
9. Du, Y., Smith, M. A., Miller, C. M., and Kern, T. S. (2002). Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J. Neurochem. 80, 771-779.
10. Fletcher, E. L., Phipps, J. A., Ward, M. M., Puthussery, T., and Wilkinson-Berka, J. L. (2007). Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr. Pharm. Des. 13, 2699-2712.
11. Garhofer, G., Zawinka, C., Resch, H., Kothy, P., Schmetterer, L., and Dorner, G. T. (2004). Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br. J. Ophthalmol. 88, 887-891.
12. Hammes, H. P., Martin, S., Feder-lin, K., Geisen, K., and Brownlee, M. (1991). Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. U.S.A. 88, 11555-11558. Kern, T. S., and Engerman, R. L. (2001). Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50,1636-1642.
13. Kern, T. S., Tang, J., Mizutani, M., Kowluru, R. A., Nagaraj, R. H., Romeo, G., Podesta, F., and Lorenzi, M. (2000). Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galac-tosemia. Invest. Ophthalmol. Vis. Sci. 41,3972-3978.
14. Kirwin, S. J., Kanaly, S. T., Linke, N. A., and Edelman, J. L. (2009). Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci. 50, 5396-5404.
15. Klein, R., Klein, B. E., Moss, S. E., Wong, T. Y., Hubbard, L., Cruickshanks, K. J., and Palta, M. (2004). The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch. Ophthalmol. 122, 76-83.
16. Kowluru, R. A., Engerman, R. L., and Kern, T. S. (2000). Abnormalities of retinal metabolism in diabetes or experimental galactosemiaVIII. Prevention by aminoguanidine. Curr. Eye Res. 21,814-819.
17. Mandecka, A., Dawczynski, J., Blum, M., Muller, N., Kloos, C., Wolf, G., Vilser, W., Hoyer, H., and Muller, U. A. (2007). Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30, 3048-3052.
18. Metea, M. R., and Newman, E. A. (2006). Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J. Neurosci. 26,2862-2870.
19. Mishra, A., and Newman, E. A. (2010). Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia 58,1996-2004.
20. Mizutani, M., Kern, T. S., and Lorenzi, M. (1996). Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 97, 2883-2890.
21. Naka, K. I., and Rushton, W. A. (1966). S-potentials from luminosity units in the retina of fish (Cyprinidae). J. Physiol.(Lond.) 185, 587-599.
22. Nguyen, T. T., Kawasaki, R., Wang, J. J., Kreis, A. J., Shaw, J., Vilser, W., and Wong, T.Y. (2009). Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32,2075-2080.
23. Pemp, B., Garhofer, G., Weigert, G., Karl, K., Resch, H., Wolzt, M., and Schmetterer, L. (2009). Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest. Oph-thalmol Vis. Sci. 50, 4029-4032.
24. Perry, R. E., Swamy, M. S., and Abraham, E. C. (1987). Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp. Eye Res. 44, 269-282.
25. Phipps, J. A., Fletcher, E. L., and Vingrys, A. J. (2004). Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest. Ophthalmol. Vis. Sci. 45, 4592-4600.
26. Polak, K., Schmetterer, L., and Riva, C. E. (2002). Influence of flicker frequency on flicker-induced changes of retinal vessel diameter. Invest. Ophthalmol Vis. Sci. 43, 2721-2726.
27. Riva, C. E., Logean, E., and Falsini, B. (2005). Visually evoked hemody-namical response and assessment of neurovascular coupling in the optic nerve and retina. Prog. Retin. Eye Res. 24, 183-215.
28. Roy, M. S., Klein, R., and Janal, M. N. (2011). Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus. Arch. Ophthalmol. 129, 8-15.
29. Srienc, A. I., Kurth-Nelson, Z. L., and Newman, E. A. (2010). Imaging retinal blood flow with laser speckle flowmetry. FrontNeuroenerg. 2:128. doi:10.3389/fnene.2010.00128
30. Zheng, L., Du, Y., Miller, C., Gubitosi-Klug, R. A., Ball, S., Berkowitz, B. A., and Kern, T. S. (2007). Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50,1987-1996.